Intimation of Closure of Trading Window for the Quarter ended December 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venmax Drugs and Pharmaceuticals has informed the BSE that the trading window for its securities will be closed for all insiders, designated persons, and their immediate relatives starting January 1, 2026. The closure is in line with SEBI's Insider Trading Regulations, 2015 and the company's internal code of conduct. The trading window will reopen 48 hours after the company declares its unaudited financial results for the quarter ended December 31, 2025 (Q3 FY26). The date of the board meeting to approve these results will be communicated separately.
This is a routine compliance filing with no direct impact on shareholders or stock price. It simply restricts insider trading until Q3 FY26 results are announced, which is standard practice before results declaration.